FindTrial
Sign In

To evaluate the effect of Haridradi vati in Stanapeeda with respect to Breast Engorgement in Sutika Avastha.

Single Arm, open label clinical study to evaluate the effect of Haridradi vati in Stanapeeda with respect to Breast Engorgement in Sutika Avastha. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091966
Enrollment
50
Registered
2025-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O922- Other and unspecified disorders ofbreast associated with pregnancy and the puerperium

Interventions

None listed

Sponsors

Sumatibhai Shah Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Puerperal women after vaginal or Caesarean section diagnosed with Stanapeeda with respect to Breast Engorgement with age group between 19-35 years

Exclusion criteria

Exclusion criteria: 1. BREAST ABSCESS 2. BREAST WOUND EXAMPLE-CRACK NIPPLES 3. BREAST FIBROADENOMA 4. MASTITIS 5. CA BREAST AND OTHER SKIN LESIONS OR DISEASE.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Haridradi Vati 250mg thrice daily after meal(Adhobhakta) for consecutive 5 days in Stanapeeda with respect to Breast Engorgement in Sutika Avastha. Assessment of pain, fever, redness, warmness and fatigue.Timepoint: There will be 5 total follow ups-1st,2nd,4th,5th and 6th day.—

Secondary

MeasureTime frame
1. Literature study of Stanapeeda with respect to Breast Engorgement. 2. Standard procedure for preparation of Haridradi Vati. 3.Raw drug authentication & standardization. 4.Clinical trial & data collection. 5.Statistical analysis & conclusion. 6.To observe adverse effects if any.Timepoint: There will be 5 total follow ups- 1st,2nd,4th,5th & 6th day.—

Countries

India

Contacts

Public ContactDr Poonam Vinayak Unde

Sumatibhai Shah Ayurved Mahavidyalaya

truptigawade13@gmail.com9881840224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026